12 Labs

Ashu Dubey recognized a fundamental problem plaguing the health app industry: user engagement was dismal. Most health and fitness apps saw enthusiastic adoption for a week or two before users dropped off completely. As a data scientist and product-focused engineer, Ashu saw an opportunity to apply machine learning and data science to solve this engagement crisis. The market was massive—the US health industry alone exceeded $80 billion—and the solution required deep technical expertise.

12 Labs launched Applays, a comprehensive weight loss application available on both iOS and Android. The app featured multiple engagement mechanisms: users could log meals, track workouts, monitor weight, and participate in quizzes. Rather than rushing to monetize immediately, the team deliberately kept the app free to focus entirely on fixing engagement and user experience. This contrasted sharply with competitors who prioritized quick revenue over product quality.

With Mark Benioff's investment connection through co-founder Durga (who had previously worked at Salesforce), the company secured approximately $1 million in a priced round from the Salesforce founder and prominent Bay Area angels. Durga's track record included experience at successful startups like Palo Alto Networks from their early stages, while Ashu had previously founded Fast Forward India, a successful nonprofit focused on computer literacy for underprivileged children. This combination of execution experience convinced investors to bet on the team despite zero revenue.

The free-to-play model generated extraordinary traction: over 500,000 downloads and approximately 75,000 monthly active users by early 2016. The real innovation was the engagement platform for wearables that powered Applays—this platform alone increased retention seven-fold. Instead of the typical 15% of users returning after 30 days, the platform helped achieve dramatically higher retention rates. This success demonstrated that the engagement problem could be solved with the right data science approach, validating the entire premise.

By early 2016, 12 Labs had successfully validated product-market fit through massive user adoption and proof of the engagement platform's effectiveness. While the Applays app remained free, the underlying engagement platform generated significant investor interest from potential enterprise customers interested in licensing the technology. The company was positioned to scale through both direct app growth and B2B licensing of their proprietary engagement technology to other health and wellness platforms.